Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) logged adverse reactions to Melanotan II and warned the public of serious health risks. The UK agency is also concerned that MT-II is increasingly being marketed to younger consumers with bright colors and branding and has been focused on removing UK-facing sales websites advertising MT-II since 2011
Of greatest concern with overdosage or chronic overuse would be copper toxicity
Alternatively, nicotinic acid may be used as a precursor for NAD+ synthesis
Our team routinely counsels clients on compounding compliance under Sections 503A and 503B, FDA enforcement trends, and risk mitigation strategies related to bulk drug substances and evolving agency guidance
US$ 28.91
US$ 20.48
US$ 26.76
